🟢 MetaVia is trading 5% up in pre-market with broader risk-on sentiment likely driving gains

MetaVia is trading 5.06% up at $1.66, likely driven by broader risk-on sentiment; no fresh company-specific announcement, earnings release, or analyst action was identified for September 18, 2026.

• The Nasdaq Composite is up 0.60%, and U.S. futures are higher.
• The latest identifiable company news remains September 9 preclinical DA-1726 data, not a new overnight catalyst.